Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nina Gale, Nina Zidar, Vinko Kambič, Mario Poljak & Andrej Cör. (1997) Epidermal Growth Factor Receptor, c-erbB-2 and p53 Overexpressions in Epithelial Hyperplastic Lesions of the Larynx. Acta Oto-Laryngologica 117:sup527, pages 105-110.
Read now
Read now
Wolfgang Bergler, Georg Petroianu, Cathrine Juncker & Karl Hörmann. (1996) Correlation of Transforming Growth Factor Alpha and Epidermal Growth Factor Receptor in Oropharyngeal Carcinomas. Acta Oto-Laryngologica 116:3, pages 486-489.
Read now
Read now
JesÄS Bujía & Thomas P. U. Wustrow. (1993) Heterologous Epidermal Growth Factor Receptor (EGF-R) Expression in Larynx Cancer Cell Lines: Evidence for the Existence of Structurally Modified Receptors. Acta Oto-Laryngologica 113:6, pages 789-792.
Read now
Read now
Maria E. Christensen, Marianne H. Therkildsen, Bente L. Hansen, Georg N. Hansen & Poul Bretlau. (1992) Immunohistochemical Detection of Epidermal Growth Factor Receptor in Laryngeal Squamous Cell Carcinomas. Acta Oto-Laryngologica 112:4, pages 734-738.
Read now
Read now
Mamoru Miyaguchi, Jan Olofsson & Henrik B. Hellquist. (1991) Immunohistochemical Study of Epidermal Growth Factor Receptor in Severe Dysplasia and Carcinoma in situ of the Vocal Cords. Acta Oto-Laryngologica 111:1, pages 149-152.
Read now
Read now
Articles from other publishers (28)
Anna Rzepakowska, Wioletta Pietruszewska, Michał Żurek, Maria Molga-Magusiak, Michał Leszczyński & Kazimierz Niemczyk. (2023) Preoperative lymphocyte count, neutrophil to lymphocyte and platelet to lymphocyte ratio predict the recurrence with progression and cancerization in vocal fold lesions—retrospective study. PeerJ 11, pages e15642.
Crossref
Crossref
Henrik Hellquist, Alfio Ferlito, Antti A. Mäkitie, Lester D. R. Thompson, Justin A. Bishop, Abbas Agaimy, Juan C. Hernandez-Prera, Douglas R. Gnepp, Stefan M. Willems, Pieter J. Slootweg & Alessandra Rinaldo. (2020) Developing Classifications of Laryngeal Dysplasia: The Historical Basis. Advances in Therapy 37:6, pages 2667-2677.
Crossref
Crossref
Linah A. Shahoumi & W. Andrew Yeudall. (2019) Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine. EPMA Journal 10:3, pages 291-305.
Crossref
Crossref
Gianluigi Mazzoccoli, Stefano Castellana, Massimo Carella, Orazio Palumbo, Cristiana Tiberio, Caterina Fusilli, Daniele Capocefalo, Tommaso Biagini, Tommaso Mazza & Lorenzo Lo Muzio. (2017) A primary tumor gene expression signature identifies a crucial role played by tumor stroma myofibroblasts in lymph node involvement in oral squamous cell carcinoma. Oncotarget 8:62, pages 104913-104927.
Crossref
Crossref
Zhuo Chen, Suresh Ramalingam & Dong M. Shin. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
709
726
.
Sumita Trivedi, Clark A. Rosen & Robert L. Ferris. (2016) Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer. Current Opinion in Otolaryngology & Head and Neck Surgery 24:2, pages 121-127.
Crossref
Crossref
H E Amer, S A Asker & S A Mazroa. (2011) Structural changes and immunohistochemical localisation of epidermal growth factor receptor in the true vocal fold of female albino rats administered anabolic, androgenic steroids, and effects of anti-androgen therapy. The Journal of Laryngology & Otology 125:8, pages 829-836.
Crossref
Crossref
K. Kian Ang. (2008) Multidisciplinary Management of Locally Advanced SCCHN: Optimizing Treatment Outcomes. The Oncologist 13:8, pages 899-910.
Crossref
Crossref
Carsten Sticht, Kolja Freier, Karl Knöpfle, Christa Flechtenmacher, Susanne Pungs, Christof Hofele, Meinhard Hahn, Stefan Joos & Peter Lichter. (2008) Activation of MAP Kinase Signaling Through ERK5 But Not ERK1 Expression Is Associated with Lymph Node Metastases in Oral Squamous Cell Carcinoma (OSCC). Neoplasia 10:5, pages 462-IN4.
Crossref
Crossref
Giovanni Almadori, Francesco Bussu & Gaetano Paludetti. (2008) Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?. Current Opinion in Otolaryngology & Head & Neck Surgery 16:2, pages 117-126.
Crossref
Crossref
David G. Pfister, Yungpo Bernard Su, Dennis H. Kraus, Suzanne L. Wolden, Eric Lis, Timothy B. Aliff, Andrew J. Zahalsky, Simone Lake, Michael N. Needle, Ashok R. Shaha, Jatin P. Shah & Michael J. Zelefsky. (2006) Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm. Journal of Clinical Oncology 24:7, pages 1072-1078.
Crossref
Crossref
Terry A. Day, Angela Chi, Brad Neville & James R. Hebert. (2005) Prevention of head and neck cancer. Current Oncology Reports 7:2, pages 145-153.
Crossref
Crossref
Matthew A. Ginos, Grier P. Page, Bryan S. Michalowicz, Ketan J. Patel, Sonja E. Volker, Stefan E. Pambuccian, Frank G. Ondrey, George L. Adams & Patrick M. Gaffney. (2004) Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck. Cancer Research 64:1, pages 55-63.
Crossref
Crossref
Jose Sullivan Lopez‐Gonzalez, Lissete Cristerna‐Sanchez, Maria Eugenia Vazquez‐Manriquez, Gonzalo Jimenez‐Orci & Dolores Aguilar‐Cazares. (2016) Localization and Level of Expression of β‐Catenin in Human Laryngeal Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery 130:1, pages 89-93.
Crossref
Crossref
Francisco RobertMark P. EzekielSharon A. SpencerRuby F. MeredithJames A. BonnerM. B. KhazaeliMansoor N. SalehDelicia CareyAlbert F. LoBuglioRichard H. WheelerMichael R. CooperHarlan W. Waksal. (2001) Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer. Journal of Clinical Oncology 19:13, pages 3234-3243.
Crossref
Crossref
M.A. Nagai. (1999) Genetic alterations in head and neck squamous cell carcinomas. Brazilian Journal of Medical and Biological Research 32:7, pages 897-904.
Crossref
Crossref
A. Burkhardt & E. Meyer-Breiting. 1999. HNO-Pathologie. HNO-Pathologie
547
1064
.
G. C. Sahoo. (1998) Oncogens in ENT and head and neck — a review. Indian Journal of Otolaryngology and Head & Neck Surgery 50:4, pages 320-325.
Crossref
Crossref
Dorothy Uhlman, George Adams, Jeffrey M. Resnick, Gloria A. Niehans, Dennis Knapp, Markus Gapany & Waclaw Jaszcz. (2016) Cervical Lymph Node Status and Survival in Laryngeal Carcinoma: Prognostic Factors. Annals of Otology, Rhinology & Laryngology 104:9, pages 685-694.
Crossref
Crossref
Q. H. Wen, T. Nishimura, T. Miwa, I. Nagayama & M. Furukawa. (2007) Expression of EGF, EGFR and PCNA in laryngeal lesions. The Journal of Laryngology & Otology 109:7, pages 630-636.
Crossref
Crossref
David S. Salomon, Ralf Brandt, Fortunato Ciardiello & Nicola Normanno. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Critical Reviews in Oncology/Hematology 19:3, pages 183-232.
Crossref
Crossref
M. Miyaguchi, T. Kawahara, S. Sakai, H. Kuwabara & H. Sakamoto. (1994) A correlation of argyrophilic nucleolar organizer regions with prognoses in patients with maxillary sinus squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 251:4, pages 229-232.
Crossref
Crossref
J. L. Formento, M. Francoual, O. Dassonville, J. Santini, A. Ramaioli, G. Milano, M. Schneider & F. Demard. 1994. Cancer Treatment An Update. Cancer Treatment An Update
225
233
.
J.A. WILSON, M.J.C. ROGERS, R.A. HAWKINS, H.M. GILMOUR & A.G.D. MARAN. (1993) Epidermal growth factor receptors and oestrogen receptors in the head and neck. Clinical Otolaryngology 18:1, pages 66-68.
Crossref
Crossref
Maurizio Maurizi, Giovanni Scambia, Pierluigi Benedetti Panici, Gabriella Ferrandina, Giovanni Almadori, Gaetano Paludetti, Rosa De Vincenzo, Mariagrazia Distefano, Domenico Brinchi, Gabriella Cadoni & Salvatore Mancuso. (2006) EGF receptor expression in primary laryngeal cancer: Correlation with clinico‐pathological features and prognostic significance. International Journal of Cancer 52:6, pages 862-866.
Crossref
Crossref
Eddi Di Marco, Enrico Albanese, Stefano Benso, Fabio Beatrice, Ranieri Cancedda & Salvatore Toma. (1992) Expression of epidermal growth factor receptor and transforming growth factor α in human larynx carcinoma. Cancer Letters 65:3, pages 189-199.
Crossref
Crossref
MAMORU MIYAGUCHI, JAN OLOFSSON & HENRIK B.HELLQUIST. (2009) Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clinical Otolaryngology & Allied Sciences 16:5, pages 466-469.
Crossref
Crossref
MAMORU MIYAGUCHI, JAN OLOFSSON & HENRIK B. HELLQUIST. (1991) Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clinical Otolaryngology 16:5, pages 466-469.
Crossref
Crossref